Financhill
Sell
11

ADAP Quote, Financials, Valuation and Earnings

Last price:
$0.24
Seasonality move :
-0.05%
Day range:
$0.23 - $0.25
52-week range:
$0.20 - $1.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.35x
P/B ratio:
6.03x
Volume:
1.3M
Avg. volume:
677.9K
1-year change:
-70.87%
Market cap:
$64.2M
Revenue:
$178M
EPS (TTM):
-$0.31

Adaptimmune Therapeutics PLC SEC Filings

Company Filed Form Type Description
ADAP
Adaptimmune Therapeutics PLC
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
08/09/2023 10-Q 10-Q filing on 08/09/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
05/12/2023 10-Q 10-Q filing on 05/12/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
11/08/2022 10-Q 10-Q filing on 11/08/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
05/09/2022 10-Q 10-Q filing on 05/09/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
11/04/2021 10-Q 10-Q filing on 11/04/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
08/09/2021 10-Q 10-Q filing on 08/09/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
05/06/2021 10-Q 10-Q filing on 05/06/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
08/06/2020 10-Q 10-Q filing on 08/06/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
05/28/2020 10-Q 10-Q filing on 05/28/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
05/14/2020 10-Q 10-Q filing on 05/14/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
02/27/2020 10-K 10-K filing on 02/27/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
11/06/2019 10-Q 10-Q filing on 11/06/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
05/06/2019 10-Q 10-Q filing on 05/06/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
02/27/2019 10-K 10-K filing on 02/27/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
03/15/2018 10-K 10-K filing on 03/15/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
05/10/2017 10-Q 10-Q filing on 05/10/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
04/06/2017 10-Q 10-Q filing on 04/06/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
03/13/2017 10-K 10-K filing on 03/13/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
11/10/2016 10-Q 10-Q filing on 11/10/2016 View Form
ADAP
Adaptimmune Therapeutics PLC
08/08/2016 10-Q 10-Q filing on 08/08/2016 View Form
ADAP
Adaptimmune Therapeutics PLC
05/12/2016 10-Q 10-Q filing on 05/12/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Planet Labs Stock Up Today?
Why Is Planet Labs Stock Up Today?

Planet Labs (NYSE: PL) opened Friday trading with an unmistakable…

Is Coherent Stock Breaking Out?
Is Coherent Stock Breaking Out?

Coherent (NYSE: COHR) has spent the better part of two years…

What Is The Long-term Outlook for AMC Stock?
What Is The Long-term Outlook for AMC Stock?

Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 53x

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
95
AVAV alert for Jun 27

AeroVironment [AVAV] is up 2.13% over the past day.

Buy
70
AEVA alert for Jun 27

Aeva Technologies [AEVA] is up 8.52% over the past day.

Buy
88
TSSI alert for Jun 27

TSS [TSSI] is down 2.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock